Luca Issi
Analyst
RBC Capital Markets
Equibles does not estimate personal net worth.
About Luca Issi
Luca Issi is recorded as Analyst at RBC Capital Markets. Luca Issi has spoken on 3 earnings calls and 3 other investor events across 5 companies, most recently for Alnylam Pharmaceuticals, Inc. on October 29, 2026. Those appearances were for Alnylam Pharmaceuticals, Inc. (ALNY), Beam Therapeutics Inc. (BEAM), Ionis Pharmaceuticals Inc (IONS), uniQure N.V. (QURE) and Wave Life Sciences, Inc. (WVE). The companies whose calls Luca Issi spoke on are classified in the Healthcare sector.
Luca Issi on recent calls
“Maybe, Jeff, I appreciate you're not going to guide 2027 today and appreciate you're not going to guide J.P. Morgan as well. Can I maybe check your temperature and how you're thinking more broadly about your guided 25% plus total revenue CAGR throughout year-end 2030?”
“The Capital Market, today's our great privilege to have Beam as part of our 2026 Global Healthcare Conference. Representing the company, we have John Evans, Chief Executive Officer.”
“Representative of the company, we have Holly Kordasiewicz, who is the Chief Development Officer. Holly, thanks so much for joining us. How are you doing today?”
“And today's our great privilege to have Unicure as part of the 2026 Global Healthcare Conference, representing the company we have Matt Capusta, Chief Executive Officer.”
“Yesterday, AstraZeneca printed a pretty meaningful miss for TTRPN, and we knew it was actually down 35% Q over Q. So I guess from a competitor standpoint. Is Al Nilem a net beneficiary of that mess in PN?”
Affiliation history
-
RBC Capital Markets
Analyst
Source not stated
Current
Company network
uniQure N.V.
QURE
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-05-19
View calls and events